Hiroaki Okazaki

7.1k total citations
75 papers, 5.0k citations indexed

About

Hiroaki Okazaki is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Hiroaki Okazaki has authored 75 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 30 papers in Molecular Biology and 15 papers in Biochemistry. Recurrent topics in Hiroaki Okazaki's work include Cholesterol and Lipid Metabolism (32 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Lipid metabolism and biosynthesis (15 papers). Hiroaki Okazaki is often cited by papers focused on Cholesterol and Lipid Metabolism (32 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Lipid metabolism and biosynthesis (15 papers). Hiroaki Okazaki collaborates with scholars based in Japan, United States and Denmark. Hiroaki Okazaki's co-authors include Shun Ishibashi, Jun-ichi Osuga, Naoya Yahagi, Hitoshi Shimano, Yoko Iizuka, Yoshiaki Tamura, Nobuhiro Yamada, Ken Ohashi, Takanari Gotoda and Michiyo Amemiya-Kudo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Hiroaki Okazaki

74 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Okazaki Japan 31 2.5k 2.1k 1.1k 994 935 75 5.0k
Ken Ohashi Japan 37 3.2k 1.3× 2.5k 1.2× 1.1k 1.1× 1.3k 1.3× 1.1k 1.2× 85 6.4k
Michiyo Amemiya-Kudo Japan 19 2.0k 0.8× 1.9k 0.9× 861 0.8× 827 0.8× 585 0.6× 22 3.9k
Takashi Matsuzaka Japan 39 3.3k 1.3× 2.1k 1.0× 1.0k 1.0× 1.6k 1.6× 1.2k 1.3× 101 6.5k
Russell A. DeBose‐Boyd United States 35 3.8k 1.5× 3.1k 1.5× 1.1k 1.1× 754 0.8× 1.1k 1.2× 62 6.4k
Lawrence W. Castellani United States 41 2.2k 0.9× 1.8k 0.9× 651 0.6× 852 0.9× 541 0.6× 71 6.6k
Michael R. Briggs United States 20 4.5k 1.8× 1.8k 0.9× 648 0.6× 856 0.9× 1.1k 1.2× 25 6.4k
Todd G. Kirchgessner United States 36 1.8k 0.7× 1.2k 0.6× 713 0.7× 688 0.7× 545 0.6× 43 5.1k
Yuriy K. Bashmakov Russia 21 3.4k 1.3× 3.6k 1.7× 1.2k 1.2× 1.7k 1.7× 870 0.9× 43 6.9k
Scott S. Sundseth United States 26 3.0k 1.2× 1.4k 0.7× 641 0.6× 525 0.5× 494 0.5× 41 4.9k
Jun-ichi Osuga Japan 42 3.7k 1.5× 3.1k 1.5× 1.8k 1.7× 1.6k 1.6× 1.2k 1.3× 85 7.8k

Countries citing papers authored by Hiroaki Okazaki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Okazaki more than expected).

Fields of papers citing papers by Hiroaki Okazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Okazaki. The network helps show where Hiroaki Okazaki may publish in the future.

Co-authorship network of co-authors of Hiroaki Okazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Okazaki. A scholar is included among the top collaborators of Hiroaki Okazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Okazaki. Hiroaki Okazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogura, Masatsune, Sachiko Okazaki, Hiroaki Okazaki, et al.. (2024). Transitional Medicine of Intractable Primary Dyslipidemias in Japan. Journal of Atherosclerosis and Thrombosis. 31(5). 501–519. 4 indexed citations
2.
Kondo, Yasuyuki, Koichi Watanabe, Hiroaki Okazaki, et al.. (2023). A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from <i>MEN1</i> inactivation which recurred 15 years after the initial resection. Endocrine Journal. 70(6). 573–579. 1 indexed citations
3.
Okazaki, Hiroaki, et al.. (2023). A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels. Journal of clinical lipidology. 17(6). 834–838. 2 indexed citations
4.
Eguchi, Jun, Kazuya Miyashita, Isamu Fukamachi, et al.. (2018). GPIHBP1 autoantibody syndrome during interferon β1a treatment. Journal of clinical lipidology. 13(1). 62–69. 15 indexed citations
5.
Amemiya-Kudo, Michiyo, Yoshinori Takeuchi, Hiroaki Okazaki, et al.. (2011). Suppression of the Pancreatic Duodenal Homeodomain Transcription Factor-1 (Pdx-1) Promoter by Sterol Regulatory Element-binding Protein-1c (SREBP-1c). Journal of Biological Chemistry. 286(32). 27902–27914. 12 indexed citations
6.
Ohta, Keisuke, Motohiro Sekiya, Hiroshi Uozaki, et al.. (2010). Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement. Biochemical and Biophysical Research Communications. 404(1). 254–260. 7 indexed citations
7.
Okazaki, Hiroaki, Joseph L. Goldstein, Michael S. Brown, & Guosheng Liang. (2009). LXR-SREBP-1c-Phospholipid Transfer Protein Axis Controls Very Low Density Lipoprotein (VLDL) Particle Size. Journal of Biological Chemistry. 285(9). 6801–6810. 76 indexed citations
8.
Igarashi, Masaki, Jun-ichi Osuga, Masashi Isshiki, et al.. (2009). Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence. Journal of Lipid Research. 51(2). 274–285. 26 indexed citations
9.
Yahagi, Naoya, Hitoshi Shimano, Kiyoshi Hasegawa, et al.. (2005). Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. European Journal of Cancer. 41(9). 1316–1322. 205 indexed citations
10.
Okazaki, Hiroaki, Motowo Mizuno, Junichirou Nasu, et al.. (2004). Difference in Ulex europaeus agglutinin I–binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis. Journal of Laboratory and Clinical Medicine. 143(3). 169–174. 3 indexed citations
11.
Yahagi, Naoya, Hitoshi Shimano, Takashi Matsuzaka, et al.. (2004). p53 Involvement in the Pathogenesis of Fatty Liver Disease. Journal of Biological Chemistry. 279(20). 20571–20575. 102 indexed citations
12.
Tamura, Yoshiaki, Hideki Adachi, Jun-ichi Osuga, et al.. (2003). FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products. Journal of Biological Chemistry. 278(15). 12613–12617. 150 indexed citations
13.
Mizuno, Motowo, Hiroaki Okazaki, Kazuhide Yamamoto, et al.. (2002). ADVANCES IN THE DEVELOPMENT OF A RELIABLE ASSAY FOR THE MEASUREMENT OF STOOL DECAY-ACCELERATING FACTOR IN THE DETECTION OF COLORECTAL CANCER. Journal of Immunoassay and Immunochemistry. 23(4). 497–507. 10 indexed citations
14.
Yahagi, Naoya, Hitoshi Shimano, Alyssa H. Hasty, et al.. (2002). Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance in Lep/Lep Mice. Journal of Biological Chemistry. 277(22). 19353–19357. 301 indexed citations
15.
Oda, Takuzo, et al.. (1959). Histo-chemical and cytochemical studies on the succinic dehydroge-nase system with three ditetrazolium salts, NT, Nitro-NT, and Nitro-Bt. Okayama University Scientific Achievement Repository (Okayama University). 13(1). 31–44. 6 indexed citations
16.
Oda, Takuzo & Hiroaki Okazaki. (1958). An analytical study on the reduction of neotetrazolium chloride by the terminal electron transport system. Okayama University Scientific Achievement Repository (Okayama University). 12(3). 193–204. 13 indexed citations
17.
Oda, Takuzo, et al.. (1958). An electron-microscopic study on lipogenesis. Okayama University Scientific Achievement Repository (Okayama University). 12(1). 29–41. 9 indexed citations
18.
Oda, Takuzo, Hiroaki Okazaki, & Shuji Seki. (1958). New methods for the histochemical and cytochemical demonstrtion of cytochrome c oxidase and of cytochrome c- cytochrome oxidase system. Okayama University Scientific Achievement Repository (Okayama University). 12(4). 302–309. 4 indexed citations
19.
Oda, Takuzo, Akira Sakai, & Hiroaki Okazaki. (1958). Cytochemicar demonstration of the sites of activity of the terminal electron transport system with the electron microscope. Okayama University Scientific Achievement Repository (Okayama University). 12(3). 205–515. 1 indexed citations
20.
Oda, Takuzo, Shuji Seki, & Hiroaki Okazaki. (1958). New colorimetic methods for the estimation of cytochrome c oxidase and of cytochrome c-cyto-chrome oxidase system. Okayama University Scientific Achievement Repository (Okayama University). 12(4). 293–301. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026